Healthcare -
Biotechnology - NASDAQ - US
$ 14.01
2.86 %
$ 1.06 B
Market Cap
-4.61
P/E
REPL - TOTAL CURRENT ASSETS
Total Current Assets REPL - Replimune Group, Inc.
434 M
LAST VALUE
3.61%
2 YEAR CAGR
25.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR